Effect of Low-dose Interferon-alfa2a on Peri-operative Immune Suppression
Status:
Not yet recruiting
Trial end date:
2023-12-01
Target enrollment:
Participant gender:
Summary
The aim of this randomized double-blinded placebo-controlled phase 2 study is to determine
efficacy of preoperative treatment with interferon-alfa2a in patients with pMMR colon cancer
on perioperative immune suppression and infiltration of lymphocytes in the primary tumor.